147 related articles for article (PubMed ID: 35712667)
1. Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for Gene Expression Profiling From Clinical Formalin-Fixed Paraffin-Embedded Tumor Specimens.
Shi Y; Ma X; Shen W; Liu T; Liang L; Liu S; Shen Z; Zhang Y; Zhang P
Front Cell Dev Biol; 2022; 10():899353. PubMed ID: 35712667
[TBL] [Abstract][Full Text] [Related]
2. Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform.
Qi Z; Wang L; Desai K; Cogswell J; Stern M; Lawson B; Kerkar SP; Vitazka P
J Mol Diagn; 2019 Sep; 21(5):796-807. PubMed ID: 31255795
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis.
Inaki K; Shibutani T; Maeda N; Eppenberger-Castori S; Nicolet S; Kaneda Y; Koyama K; Qiu Y; Wakita K; Murakami M
PLoS One; 2022; 17(9):e0274140. PubMed ID: 36137139
[TBL] [Abstract][Full Text] [Related]
4. Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy.
Zhang L; Cham J; Cooley J; He T; Hagihara K; Yang H; Fan F; Cheung A; Thompson D; Kerns BJ; Fong L
J Immunol Methods; 2021 Jul; 494():113041. PubMed ID: 33753096
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues.
Kwak M; Erdag G; Slingluff CL
Sci Rep; 2020 Oct; 10(1):18336. PubMed ID: 33110110
[TBL] [Abstract][Full Text] [Related]
6. Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.
Talla SB; Rempel E; Endris V; Jenzer M; Allgäuer M; Schwab C; Kazdal D; Stögbauer F; Volckmar AL; Kocsmar I; Neumann O; Schirmacher P; Zschäbitz S; Duensing S; Budczies J; Stenzinger A; Kirchner M
Genes Chromosomes Cancer; 2020 Jul; 59(7):406-416. PubMed ID: 32212351
[TBL] [Abstract][Full Text] [Related]
7. Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma.
Gupta S; McCann L; Chan YGY; Lai EW; Wei W; Wong PF; Smithy JW; Weidler J; Rhees B; Bates M; Kluger HM; Rimm DL
J Immunother Cancer; 2019 Sep; 7(1):254. PubMed ID: 31533832
[TBL] [Abstract][Full Text] [Related]
8. Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach.
Mao Y; Gide TN; Adegoke NA; Quek C; Maher N; Potter A; Patrick E; Saw RPM; Thompson JF; Spillane AJ; Shannon KF; Carlino MS; Lo SN; Menzies AM; da Silva IP; Long GV; Scolyer RA; Wilmott JS
J Transl Med; 2023 Apr; 21(1):257. PubMed ID: 37055772
[TBL] [Abstract][Full Text] [Related]
9. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
Tyekucheva S; Martin NE; Stack EC; Wei W; Vathipadiekal V; Waldron L; Fiorentino M; Lis RT; Stampfer MJ; Loda M; Parmigiani G; Mucci LA; Birrer M
J Mol Diagn; 2015 Jul; 17(4):374-81. PubMed ID: 25937617
[TBL] [Abstract][Full Text] [Related]
10. Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing.
Paluch BE; Glenn ST; Conroy JM; Papanicolau-Sengos A; Bshara W; Omilian AR; Brese E; Nesline M; Burgher B; Andreas J; Odunsi K; Eng K; He J; Qin M; Gardner M; Galluzzi L; Morrison CD
Oncotarget; 2017 Jan; 8(2):3197-3205. PubMed ID: 27911273
[TBL] [Abstract][Full Text] [Related]
11. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
Foy JP; Bertolus C; Michallet MC; Deneuve S; Incitti R; Bendriss-Vermare N; Albaret MA; Ortiz-Cuaran S; Thomas E; Colombe A; Py C; Gadot N; Michot JP; Fayette J; Viari A; Van den Eynde B; Goudot P; Devouassoux-Shisheboran M; Puisieux A; Caux C; Zrounba P; Lantuejoul S; Saintigny P
Ann Oncol; 2017 Aug; 28(8):1934-1941. PubMed ID: 28460011
[TBL] [Abstract][Full Text] [Related]
12. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
Ciavarella S; Vegliante MC; Fabbri M; De Summa S; Melle F; Motta G; De Iuliis V; Opinto G; Enjuanes A; Rega S; Gulino A; Agostinelli C; Scattone A; Tommasi S; Mangia A; Mele F; Simone G; Zito AF; Ingravallo G; Vitolo U; Chiappella A; Tarella C; Gianni AM; Rambaldi A; Zinzani PL; Casadei B; Derenzini E; Loseto G; Pileri A; Tabanelli V; Fiori S; Rivas-Delgado A; López-Guillermo A; Venesio T; Sapino A; Campo E; Tripodo C; Guarini A; Pileri SA
Ann Oncol; 2018 Dec; 29(12):2363-2370. PubMed ID: 30307529
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
Abramovitz M; Barwick BG; Willis S; Young B; Catzavelos C; Li Z; Kodani M; Tang W; Bouzyk M; Moreno CS; Leyland-Jones B
Br J Cancer; 2011 Nov; 105(10):1574-81. PubMed ID: 22067903
[TBL] [Abstract][Full Text] [Related]
14. Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma.
Yaseen Z; Gide TN; Conway JW; Potter AJ; Quek C; Hong AM; Long GV; Scolyer RA; Wilmott JS
Front Mol Biosci; 2022; 9():810858. PubMed ID: 35664673
[TBL] [Abstract][Full Text] [Related]
15. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
16. Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor Types.
Szabo PM; Pant S; Ely S; Desai K; Anguiano E; Wang L; Edwards R; Green G; Zhang N
J Mol Diagn; 2021 Sep; 23(9):1159-1173. PubMed ID: 34197924
[TBL] [Abstract][Full Text] [Related]
17. Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens.
Surace M; DaCosta K; Huntley A; Zhao W; Bagnall C; Brown C; Wang C; Roman K; Cann J; Lewis A; Steele K; Rebelatto M; Parra ER; Hoyt CC; Rodriguez-Canales J
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735177
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.
Kojima K; April C; Canasto-Chibuque C; Chen X; Deshmukh M; Venkatesh A; Tan PS; Kobayashi M; Kumada H; Fan JB; Hoshida Y
PLoS One; 2014; 9(1):e86961. PubMed ID: 24498002
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
